Drug
incobotulinumtoxinA clinical trials
Also written NT 201.
A product of Botulinum toxin type A; its studies count on that page too.
Keep track of what changes. Save the incobotulinumtoxinA studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
23 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 8
Merz Pharmaceuticals GmbH (8) · Merz North America, Inc. (4) · Merz Aesthetics GmbH (3) · Al Mouwasat Hospital (1) · Norwegian University of Science and Technology (1) · Buddhist Tzu Chi General Hospital (1) · University of Malaya (1) · University of Miami (1)
Related medicines
As reviewed, each with the page that says it.
- A dosage form of Botulinum toxin type A source
Studies
Open first, then newest update. How each study uses incobotulinumtoxinA is read from its arms, and is right about nine times in ten.
Testing it · 23
- Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)RecruitingPhase 2University of MiamiNCT06293300Written as BoNT A
- Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain InjuryActive, not recruitingPhase 3Merz Pharmaceuticals GmbHNCT03992404Written as NT 201
- A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United StatesActive, not recruitingPhase 3Merz North America, Inc.NCT07122193Written as NT 201
- A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)Active, not recruitingPhase 3Merz Aesthetics GmbHNCT07210463Written as NT 201
- A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the ArmCompletedPhase 2Merz Pharmaceuticals GmbHNCT04766723Written as NT 201
- Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature EjaculationCompletedNot applicableAl Mouwasat HospitalNCT07426640Written as BoNT-A
- A Study of NT 201 Doses in the Treatment of Platysma ProminenceCompletedPhase 2Merz Aesthetics GmbHNCT05773053Written as NT 201
- A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the FaceCompletedPhase 1Merz North America, Inc.NCT05784363Written as NT 201
- Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial LinesCompletedPhase 3Merz North America, Inc.NCT04622254Written as NT 201
- Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial LinesCompletedPhase 3Merz North America, Inc.NCT04594213Written as NT 201
- "Follow the Sutures". A New Procedure for Injection of Botulinum Toxin for Chronic MigraineCompletedPhase 2Norwegian University of Science and TechnologyNCT03543254Written as BoNT-A
- Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown LinesCompletedPhase 2Merz Aesthetics GmbHNCT03806933Written as NT 201
- BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel SyndromeStatus unknownPhase 2Francesco BonoNCT05411900Written as BoNT-A
- Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual DisabilityCompletedPhase 3Merz Pharmaceuticals GmbHNCT02270736Written as NT 201
- Kinematic-guided BoNT-A Treatment for ET and PD TremorStatus unknownPhase 2Western University, CanadaNCT02427646Written as BoNT-A
- Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder SyndromeCompletedPhase 2Buddhist Tzu Chi General HospitalNCT01657409Written as BoNT-A (10 injection)
- The Effectiveness of Early Botulinum Toxin A Injection for Lower Limbs Spasticity in Subacute Stroke AdultsStatus unknownPhase 4Sir Run Run Shaw HospitalNCT02505802Written as BoNT-A injection
- Botulinum Toxin-A for Sialorrhoea Treatment in Asian Adults With Neurological DiseasesCompletedPhase 2/3University of MalayaNCT02425176Written as Botulinum toxin A (BoNT-A) 50U
- Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing DisordersWithdrawnPhase 2Merz Pharmaceuticals GmbHNCT00773591Written as NT 201, a Botulinum neurotoxin type A, free of complexing proteins
- Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical DystoniaCompletedPhase 4Merz Pharmaceuticals GmbHNCT00541905Written as NT 201
See all 23 studies that test incobotulinumtoxinA →
Given in every arm · 2 — incobotulinumtoxinA is usual care beside what is tested
- Efficacy of Extracorporeal Shock Wave Therapy on SpasticityCompletedNot applicableKayseri City HospitalNCT06225024Written as BoNT A
- Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke SpasticityCompletedNot applicableJoAnn HarnarNCT00945295Written as Botulinum toxin type A, BoNT-A
Codes
What other systems call incobotulinumtoxinA · ClinicalTrials.gg INT005533
- MeSH (NLM) C545476incobotulinumtoxinAOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C545476 | incobotulinumtoxinA | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.